Pacira Pharmaceuticals, Inc. today announced results from EXCLAIM, its Phase 4 prospective, observational study to assess the use of EXPARELA for postsurgical analgesia in patients undergoing four common plastic surgery procedures.
http://www.businesswire.com/news/topix/20130412005036/en
http://www.businesswire.com/news/topix/20130412005036/en
No comments:
Post a Comment